DrugPatentWatch Database Preview
QVAR 80 Drug Profile
» See Plans and Pricing
When do Qvar 80 patents expire, and what generic alternatives are available?
Qvar 80 is a drug marketed by Teva Branded Pharm and is included in one NDA. There are seven patents protecting this drug.
This drug has one hundred and ninety-one patent family members in twenty-four countries.
The generic ingredient in QVAR 80 is beclomethasone dipropionate. There are twenty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the beclomethasone dipropionate profile page.
US ANDA Litigation and Generic Entry Outlook for Qvar 80
Indicators of Generic Entry
Summary for QVAR 80
| International Patents: | 191 |
| US Patents: | 7 |
| Applicants: | 1 |
| NDAs: | 1 |
| Bulk Api Vendors: | 57 |
| Patent Applications: | 1,788 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | QVAR 80 at DailyMed |
Paragraph IV (Patent) Challenges for QVAR 80
| Tradename | Dosage | Ingredient | NDA | Submissiondate |
|---|---|---|---|---|
| QVAR 40 | AEROSOL, METERED;INHALATION | beclomethasone dipropionate | 020911 | 2020-01-10 |
| QVAR 80 | AEROSOL, METERED;INHALATION | beclomethasone dipropionate | 020911 | 2020-01-10 |
US Patents and Regulatory Information for QVAR 80
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva Branded Pharm | QVAR 80 | beclomethasone dipropionate | AEROSOL, METERED;INHALATION | 020911-001 | Sep 15, 2000 | DISCN | Yes | No | Start Trial | Start Trial | Y | Start Trial | |||
| Teva Branded Pharm | QVAR 80 | beclomethasone dipropionate | AEROSOL, METERED;INHALATION | 020911-001 | Sep 15, 2000 | DISCN | Yes | No | Start Trial | Start Trial | Y | Start Trial | |||
| Teva Branded Pharm | QVAR 80 | beclomethasone dipropionate | AEROSOL, METERED;INHALATION | 020911-001 | Sep 15, 2000 | DISCN | Yes | No | Start Trial | Start Trial | Y | Start Trial | |||
| Teva Branded Pharm | QVAR 80 | beclomethasone dipropionate | AEROSOL, METERED;INHALATION | 020911-001 | Sep 15, 2000 | DISCN | Yes | No | Start Trial | Start Trial | Y | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for QVAR 80
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Teva Branded Pharm | QVAR 80 | beclomethasone dipropionate | AEROSOL, METERED;INHALATION | 020911-001 | Sep 15, 2000 | Start Trial | Start Trial |
| Teva Branded Pharm | QVAR 80 | beclomethasone dipropionate | AEROSOL, METERED;INHALATION | 020911-001 | Sep 15, 2000 | Start Trial | Start Trial |
| Teva Branded Pharm | QVAR 80 | beclomethasone dipropionate | AEROSOL, METERED;INHALATION | 020911-001 | Sep 15, 2000 | Start Trial | Start Trial |
| Teva Branded Pharm | QVAR 80 | beclomethasone dipropionate | AEROSOL, METERED;INHALATION | 020911-001 | Sep 15, 2000 | Start Trial | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for QVAR 80
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Africa | 201307989 | Start Trial |
| Spain | 2529229 | Start Trial |
| Hong Kong | 1222811 | Start Trial |
| South Korea | 101628934 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
